Irisin secretion is triggered by activation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α) [17], which shows promising therapeutic potential in metabolic diseases such as obesity [18, 19], insulin resistance [20, 21], and diabetes [22, 23]. Here, FNDC5 is linked to diabetes mellitus.